This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Strong Buy Stocks for December 5th
by Zacks Equity Research
LMNR, CIR, TITN, RPM and SHBI have been added to the Zacks Rank #1 (Strong Buy) List on December 5, 2022.
Can Limoneira (LMNR) Climb 29% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Limoneira (LMNR) points to a 29.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
FEMSA (FMX) to Expand Digital Payments With NetPay Buyout
by Zacks Equity Research
FEMSA (FMX) entered a deal to acquire NetPay to expand its digital payment portfolio, and support micro, small and medium-sized businesses in Mexico.
Wall Street Analysts Predict a 40% Upside in Limoneira (LMNR): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 40% in Limoneira (LMNR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Nu Skin (NUS) Dips on Q3 Earnings & Revenue Miss, View Cut
by Zacks Equity Research
Nu Skin's (NUS) third-quarter 2022 results are hurt by higher-than-anticipated macro headwinds, continued inflation, and unfavorable currency. Management lowers the full-year view.
Newell (NWL) Surpasses Q3 Earnings, Misses Sales Estimates
by Zacks Equity Research
Newell's (NWL) Q3 results reflect the adverse impacts of a tough environment, reduced inventory, inflationary pressures and unfavorable currency. Also, management slashes its 2022 view.
Keurig Dr Pepper (KDP) Q3 Earnings Meet, Sales Lag Estimates
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q3 results gain from a robust performance in its cold beverages, a recovery in the supply chain of coffee and better pricing. KDP retains its view for 2022.
Coca-Cola (KO) Q3 Earnings & Sales Beat Estimates, Stock Rises
by Zacks Equity Research
Coca-Cola's (KO) Q3 results reflect gains from an improved price/mix, increased concentrate sales and volume growth, which has aided organic sales growth across its segments.
Boston Beer (SAM) Q3 Earnings & Revenues Beat, Stock Rises
by Zacks Equity Research
Boston Beer's (SAM) Q3 results gain from strong pricing, growth in depletions and shipments in Twisted Tea, and the positive results for Hard Mountain Dew.
Zacks Industry Outlook Highlights Archer Daniels Midland, Corteva, Adecoagro, Limoneira
by Zacks Equity Research
Archer Daniels Midland, Corteva, Adecoagro, Limoneira are part of Zacks Industry Outlook article.
4 Agriculture Operations Stocks to Watch Amid Mixed Industry Trends
by Rajani Lohia
Despite high inflation and tight supply conditions, the Agriculture - Operations industry looks poised to gain from solid demand, organic product growth and innovation. Players like ADM, CTVA, AGRO and LMNR have been doing well.
Limoneira (LMNR) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 64% and 18.15%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 42.86% and 4.79%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Calavo Growers (CVGW) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Calavo (CVGW) delivered earnings and revenue surprises of 37.50% and 6.17%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
S&W Seed (SANW) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
S&W Seed (SANW) delivered earnings and revenue surprises of -80% and 5.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -45.83% and 0.99%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?
S&W Seed (SANW) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
S&W Seed (SANW) delivered earnings and revenue surprises of -52.94% and 2.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -7.69% and 21.20%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 6th
by Zacks Equity Research
EQX, LMNR, QDEL, CP, and KAR have been added to the Zacks Rank #5 (Strong Sell) List on October 6, 2021.
Limoneira (LMNR) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 11.11% and 0.75%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) to Report Q3 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ADM or LMNR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADM vs. LMNR: Which Stock Is the Better Value Option?
CTVA vs. LMNR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CTVA vs. LMNR: Which Stock Is the Better Value Option?
CTVA vs. LMNR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CTVA vs. LMNR: Which Stock Is the Better Value Option?